Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects

American Journal of Psychiatry

Volumn 156, Issue 10, 1999, Pages 1580-1589

  Akil, Mayada ^b   Pierri, Joseph N ^b   Whitehead, Richard E ^b   Edgar, Christine L ^b   Mohila, Carrie ^b   Sampson, Allan R ^b   Lewis, David A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; HALOPERIDOL;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; FEMALE; HUMAN; MALE; MENTAL DISEASE; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA;

EID: 0032819210     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.156.10.1580     Document Type: Article

References (63)

1. Snyder SH: Catecholamines in the brain as mediators of amphetamine psychosis. Arch Gen Psychiatry 1972; 27:169-179
2. Carlsson A, Lindquist M: Effect of chlorpromazine and haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 1963; 20:140-144
3. Goldstein M, Deutch AY: Dopaminergic mechanisms in the pathogenesis of schizophrenia. FASEB J 1992; 6:2413-2421
4. Grace AA: Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 1991; 41:1-24
5. Davis KL, Kahn RS, Ko G, Davidson M: Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 1991; 148:1474-1486
6. Brozoski TJ, Brown RM, Rosvold HE, Goldman PS: Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkeys. Science 1979; 205:929-932
7. Sawaguchi T, Goldman-Rakic PS: D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 1991; 251:947-950
8. Arnsten AFT, Cai JX, Murphy BL, Goldman-Rakic PS: Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology (Berl) 1994; 116:143-151
9. Meador-Woodruff JH, Haroutunian V, Powchik P, Davidson M, Davis KL, Watson SJ: Dopamine receptor transcript expression in striatum and prefrontal occipital cortex. Arch Gen Psychiatry 1997; 54:1089-1095
10. Stefanis NC, Bresnik JN, Kerwin RW, Schofield WN, McAllister G: Elevation of D4 dopamine receptor mRNA in postmortem schizophrenic brain. Mol Brain Res 1998; 53:112-119
11. Okubo Y, Suhara T, Suzuki K, Kobayashi K, Inoue O, Terasaki O, Someya Y, Sassa T, Sudo Y, Matsuchima E, Iyo M, Tateno Y, Toru M: Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 1997; 385:634-636
12. Daniel DG, Weinberger DR, Jones DW, Zigun JR, Coppola R, Handel S, Bigelow LR, Goldberg TE, Berman KF, Kleinman JE: The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J Neurosci 1991; 11:1907-1917
13. Daniel DG, Berman KF, Weinberger DR: The effect of apomorphine on regional cerebral blood flow in schizophrenia. J Neuropsychiatry 1989; 1:377-384
14. Jentsch JD, Redmond DE Jr, Elsworth JD, Taylor JR, Youngren KD, Roth RH: Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science 1997; 277:953-955
15. Lewis DA: The catecholaminergic innervation of primate prefrontal cortex. J Neural Transm 1992; 36:179-200
16. Lewis DA, Foote SL, Goldstein M, Morrison JH: The dopaminergic innervation of monkey prefrontal cortex: a tyrosine hydroxylase immunohistochemical study. Brain Res 1988; 449: 225-243
17. Williams SM, Goldman-Rakic PS: Characterization of the dopaminergic innervation of the primate frontal cortex using a dopamine-specific antibody. Cereb Cortex 1993; 3:199-222
18. Gaspar P, Berger B, Fabvret A, Vigny A, Henry JP: Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine-beta-hydroxylase. J Comp Neurol 1989; 279: 249-271
19. Lewis DA, Sesack SR, Levey AI, Rosenberg DR: Dopamine axons in primate prefrontal cortex: specificity of distribution, synaptic targets, and development, in Advances in Pharmacology. Edited by Goldstein D, Eisenhofer G, McCarty R. San Diego, Academic Press, 1998, pp 703-706
20. Glantz LA, Lewis DA: Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia: regional and diagnostic specificity. Arch Gen Psychiatry 1997; 54:943-952
21. Erickson SL, Akil M, Levey AI, Lewis DA: Postnatal development of tyrosine hydroxylase- and dopamine transporter-immunoreactive axons in monkey rostral entorhinal cortex. Cereb Cortex 1998; 8:415-427
22. Akil M, Lewis DA: The distribution of tyrosine hydroxylase-immunoreactive fibers in the human entorhinal cortex. Neuroscience 1994; 60:857-674
23. Adams JC: Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J Histochem Cytochem 1992; 40:1457-1463
24. Renfroe JB, Chronister RB, Haycock JW, Waymire JC: The localization of tyrosine hydroxylase-like immunoreactivity in the central nervous system: methodological considerations. Brain Res Bull 1984; 13:109-126
25. Ciliax BJ, Heilman C, Demchyshyn LL, Pristupa ZB, Ince E, Hersch SM, Niznik HB, Levey Al: The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 1995; 15:1714-1723
26. Lewis DA, Melchitzky DS, Haycock JW: Four isoforms of tyrosine hydroxylase are expressed in human brain. Neuroscience 1993; 54:477-492
27. Miller GW, Staley JK, Heilman CJ, Perez JT, Mash DC, Rye DB, Levey Al: Immunochemical analysis of dopamine transporter protein in Parkinson's disease. Ann Neurol 1997; 41: 530-539
28. Qian Y, Melikian HE, Rye DB, Levey Al, Blakely RD: Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies. J Neurosci 1995; 15:1261-1274
29. Janicak PG, Davis JM, Preskorn SH, Ayd FJ: Principles and Practice of Psychopharmacotherapy. Baltimore, Williams & Wilkins, 1993
30. McEvoy JP, Schooler NR, Wilson WH: Predictors of therapeutic response to haloperidol in acute schizophrenia. Psychopharmacol Bull 1991; 27:97-101
31. Light RJ: Measures of response agreement for qualitative data: some generalizations and alternatives. Psychol Bull 1971; 76:356-377
32. Rosenberg DR, Lewis DA: Postnatal maturation of the dopaminergic innervation of monkey prefrontal and motor cortices: a tyrosine hydroxylase immunonistochemical analysis. J Comp Neurol 1995; 358:383-400
33. Venator DK, Lewis DA, Finlay JM: Effects of partial dopamine loss in the medial prefrontal cortex on local baseline and stress-evoked extracellular dopamine concentrations. Neuroscience (in press)
34. Lewis DA, Hayes TL, Lund JS, Oeth KM: Dopamine and the neural circuitry of primate prefrontal cortex: implications for schizophrenia research. Neuropsychopharmacology 1992; 6: 127-134
35. Lewis DA, Campbell MJ, Foote SL, Goldstein M, Morrison JH: The distribution of tyrosine hydroxylase-immunoreactive fibers in primate neocortex is widespread but regionally specific. J Neurosci 1987; 7:279-290
36. Noack HJ, Lewis DA: Antibodies directed against tyrosine hydroxylase differentially recognize noradrenergic axons in monkey neocortex. Brain Res 1989; 500:313-324
37. Akil M, Lewis DA: The dopaminergic innervation of monkey entorhinal cortex. Cereb Cortex 1993; 3:533-550
38. Perrone-Bizzozero NI, Sower AC, Bird ED, Benowitz LI, Ivins KJ, Neve RL: Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proc Natl Acad Sci USA 1996; 93:14182-14187
39. Dean B, Hayes W, Opeskin K, Naylor L, Pavey G, Hill C, Keks N, Copolov DL: Serotonin 2 receptors and the serotonin transporter in the schizophrenic brain. Behav Brain Res 1996; 73: 169-175
40. Gurevich EV, Joyce JN: Alterations in the cortical serotonergic system in schizophrenia: a postmortem study. Biol Psychiatry 1997; 42:529-545
41. Woo T-U, Miller JL, Lewis DA: Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons. Am J Psychiatry 1997; 154:1013-1015
42. Woo T-U, Whitehead RE, Melchitzky DS, Lewis DA: A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci USA 1998; 95:5341-5346
43. Levinson AJ, Garside S, Rosebush PI, Mazurek MF: Haloperidol induces persistent down-regulation of tyrosine-hydroxylase immunoreactivity in substantia nigra but not ventral tegmental area in the rat. Neuroscience 1998; 84:201-211
44. Bogerts B, Hantsch J, Herzer M: A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics. Biol Psychiatry 1983; 18:951-969
45. Lund JS, Lund RD, Hendrickson AE, Bunt AH, Fuchs AF: The origin of efferent pathways from the primary visual cortex, area 17, of the macaque monkey as shown by retrograde transport of horseradish peroxidase. J Comp Neurol 1975; 164:287-304
46. Gilbert CD, Kelly JP: The projections of cells in different layers of the cat's visual cortex. J Comp Neurol 1975; 63:81-106
47. Snyder GL, Keller RW, Zigmond MJ: Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals. J Pharmacol Exp Ther 1990; 253:867-876
48. Park S, Holzman PS: Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry 1992; 49:975-982
49. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG: Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996; 379: 606-612
50. Murphy BL, Arnsten AFT, Goldman-Rakic PS, Roth RH: Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc Natl Acad Sci USA 1996; 93:1325-1329
51. Arnsten AFT, Goldman-Rakic PS: Noise stress impairs prefrontal cortical cognitive function in monkeys: evidence for a hyperdopaminergic mechanism. Arch Gen Psychiatry 1998; 55:362-369
52. Williams GV, Goldman-Rakic PS: Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 1995; 376:572-575
53. Goldman-Rakic PS, Lidow MS, Gallagher DW: Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex. J Neurosci 1990; 10:2125-2138
54. Thierry A-M, Tassin JP, Blanc G, Glowinski J: Selective activation of the mesocortical DA system by stress. Nature 1976; 263:242-244
55. Andreasen NC, Arndt S, Swayze V II, Cizadlo T, Flaum M, O'Leary D, Ehrhardt JC, Yuh WTC: Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science 1994; 266:294-298
56. Pakkenberg B: Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry 1990; 47:1023-1028
57. Glantz LA, Lewis DA: Prefrontal cortical pyramidal neurons exhibit decreased dendritic spine density in subjects with schizophrenia. Arch Gen Psychiatry (in press)
58. Pierri JN, Edgar CL, Lewis DA: Somal size of prefrontal cortical pyramidal neurons in the thalamic recipient zone of subjects with schizophrenia. Abstracts of the Society for Neuroscience 1998; 24:987
59. Goldman-Rakic PS, Porrino LJ: The primate mediodorsal (MD) nucleus and its projection to the frontal lobe. J Comp Neurol 1985; 242:535-560
60. Guillery RW, Feig SL, Lozsádi DA: Paying attention to the thalamic reticular nucleus. Trends Neurosci 1998; 21:28-32
61. Goldman-Rakic PS, Leranth C, Williams SM, Mons N, Geffard M: Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex. Proc Natl Acad Sci USA 1989; 86: 9015-9019
62. Yang CR, Seamans JK: Dopamine D1 receptor actions in layers V-VI rat prefrontal cortex neurons in vitro: modulation of dendritic-somatic signal integration. J Neurosci 1996; 16: 1922-1935
63. Penit-Soria J, Audinat E, Crépel F: Excitation of rat prefrontal cortical neurons by dopamine: an in vitro electrophysiological study. Brain Res 1987; 425:263-274